November 27, 2019 Regulatory InDex Pharmaceuticals Holding AB (publ) interim report January – September 2019 Read more
November 27, 2019 Regulatory InDex Pharmaceuticals Holding AB (publ) delårsrapport för januari – september 2019 Read more
October 9, 2019 Regulatory Bulletin from Extraordinary General Meeting in InDex Pharmaceuticals Holding AB (publ) Read more
October 9, 2019 Regulatory Kommuniké från extra bolagsstämma i InDex Pharmaceuticals Holding AB (publ) Read more
September 19, 2019 Regulatory Notice of Extraordinary General Meeting in InDex Pharmaceuticals Holding AB (publ) Read more
September 19, 2019 Regulatory InDex Pharmaceuticals Holding AB (publ) kallar till extra bolagsstämma Read more
September 19, 2019 Regulatory InDex Pharmaceuticals has completed a directed share issue of approximately SEK 140 million (USD 14 million) Read more
September 19, 2019 Regulatory InDex Pharmaceuticals har genomfört en riktad nyemission av aktier om cirka SEK 140 miljoner (USD 14 miljoner) Read more
September 19, 2019 Regulatory InDex Pharmaceuticals offentliggör avsikt att genomföra riktad nyemission av aktier Read more
September 19, 2019 Regulatory InDex Pharmaceuticals announces intention of a directed share issue Read more
August 27, 2019 Regulatory InDex Pharmaceuticals meets primary endpoint in the phase IIb study CONDUCT with cobitolimod in ulcerative colitis Read more
August 27, 2019 Regulatory InDex Pharmaceuticals möter primära effektmåttet i fas IIb-studien CONDUCT med cobitolimod i ulcerös kolit Read more
August 15, 2019 Regulatory InDex Pharmaceuticals Holding AB (publ) interim report January – June 2019 Read more
August 15, 2019 Regulatory InDex Pharmaceuticals Holding AB (publ) delårsrapport för januari – juni 2019 Read more
June 26, 2019 Regulatory InDex Pharmaceuticals enrolls last patient in phase IIb study CONDUCT with cobitolimod Read more
June 26, 2019 Regulatory InDex Pharmaceuticals inkluderar sista patienten i fas IIb-studien CONDUCT med cobitolimod Read more
May 6, 2019 Regulatory Bulletin from Annual General Meeting in InDex Pharmaceuticals Holding AB (publ) Read more
May 6, 2019 Regulatory InDex Pharmaceuticals Holding AB (publ) interim report January – March 2019 Read more
May 6, 2019 Regulatory InDex Pharmaceuticals Holding AB (publ) delårsrapport för januari – mars 2019 Read more
April 11, 2019 Regulatory InDex Pharmaceuticals provides status update on the patient recruitment in the CONDUCT study Read more
April 11, 2019 Regulatory InDex Pharmaceuticals ger statusuppdatering avseende patientrekryteringen i CONDUCT-studien Read more
April 5, 2019 Regulatory Notice of Annual General Meeting in InDex Pharmaceuticals Holding AB (publ) Read more
April 2, 2019 Regulatory InDex Pharmaceuticals Holding AB (publ) publishes Annual Report for 2018 Read more
April 2, 2019 Regulatory InDex Pharmaceuticals Holding AB (publ) offentliggör årsredovisning för 2018 Read more
February 20, 2019 Regulatory InDex Pharmaceuticals Holding AB (publ) bokslutskommuniké 2018 Read more